Navigation Links
Vermillion Announces the Reappointment of Officers and Confirmation of Director
Date:2/2/2010

s="xn-person">William Wallen was appointed to the Board of Directors on December 10, 2009.  He is currently the Chief Scientific Officer, Senior Vice President for Research and Development for IDEXX Laboratories and previously served on Vermillion's Scientific Advisory Board.  

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at www.vermillion.com.  

About the OVA1™ Test

The OVA1™ Test is a qualitative serum test that combines the results of five immunoassays into a single numerical score. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. The test utilizes five well-established biomarkers - Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), beta 2-Microglobulin (beta2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) - and a proprietary algorithm to determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned.

OVA1™ Test is a trademark of Vermillion Inc.

Forward-Looking Statement

Certain matters discussed in this press release contain forward-looking statements that
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillion Announces $43.05 Million Private Placement of Common Stock
2. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
3. Vermillion Files Plan of Reorganization
4. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
5. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
6. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
7. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
8. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
9. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
10. Vermillion Receives Award From the Society of Gynecologic Oncologists
11. Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , 31 mars 2015  Une équipe de ... structure atomique d,un récepteur de surface cellulaire ... formation de thromboses. Contre toute attente, cette ... nouvelles caractéristiques structurelles qui remettent en cause ... sur les récepteurs couplés aux protéines G ...
(Date:3/30/2015)... Va. , March 30, 2015  Researchers ... the Marshall University Joan C. Edwards School of ... entitled, "PSEN1 Variant in a Family with Atypical ... genetically confirmed to have a known variant of ... drug Bryostatin 1. Genetically confirmed Alzheimer,s patients as ...
(Date:3/30/2015)... NEW YORK , March 30, 2015  Check-Cap ... diagnostics company focused on the development of a preparation-free ... screening for colorectal cancer, announced today that its CEO, ... the March 31, 2015 trading day.  Neev and Check-Cap ... to commemorate the company,s initial public offering and simultaneous ...
Breaking Medicine Technology:De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 2De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 2Severe Alzheimer's Patient Responds to Bryostatin Treatment 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 4Severe Alzheimer's Patient Responds to Bryostatin Treatment 5Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3
... 2011 Novus Scientific Pte. Ltd today announced that it ... of receiving its anticipated CE Mark approval this year for ... 1st Long-Term Resorbable Synthetic Mesh. To mark the ... 11th 2011 at the Zebrastraat venue in Ghent  ( http://www.novusscientific.com/events/ ...
... Methodist West Hospital (MWH), of West Des Moines, ... Rauland,s new Responder 5 Nurse Call communication system in ... Department (ED) treatment rooms, as well as the Maternity ... wireless phones, MWH created a quiet, healing environment that ...
Cached Medicine Technology:TIGR® Matrix Surgical Mesh - Exhibited Ahead of Anticipated CE Mark Approval at European Hernia Society 2011, Ghent, Belgium 2A Quiet Healing Environment Created by Nurse Call? 2A Quiet Healing Environment Created by Nurse Call? 3A Quiet Healing Environment Created by Nurse Call? 4
(Date:3/31/2015)... . All the work that is done is performed ... upon helping our clients in maintaining their confident beautiful smiles. ... and this problem needs to be addressed as soon as ... a key role in shattering one’s confidence but they also ... importance of this problem, Lewis Clinic has started dental implants ...
(Date:3/31/2015)... 31, 2015 With nationwide predictions of ... phenomenon known as the pineapple express, the OPP is ... insurance. FEMA , "Protecting Your Business" 09/23/2014, ... tips for protecting your business. , Here are 3 ... Almost 40% of small businesses never reopen their ...
(Date:3/31/2015)... 31, 2015 Telemedicine technology is ... specialists at Barnes-Jewish Hospital to patients at Memorial ... Illinois Healthcare (SIH) system. , “Previously, when an ... maternal-fetal medicine consultation, she had to travel two ... and then talk with a Barnes-Jewish specialist,” says ...
(Date:3/30/2015)... A new legal resource site ... members who may have been prescribed Zofran, or it’s ... The site was created in response to the plea ... No. 11-10398-RWZ, filed with the United States District Court ... that this case alleged that GlaxoSmithKline gave doctors kickbacks ...
(Date:3/30/2015)... March 31, 2015 Thomas Peither ... most respected inspection readiness professionals — will conduct ... through the inspection process. , Attendees will learn ... investigator and what they look for when conducting ... exercises and roundtable discussions. This will assure attendees ...
Breaking Medicine News(10 mins):Health News:3 Statistics Every Business Owner Should Know About Flood Waters and Flood Insurance, from the Optometric Protector Plan® 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 3Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 4
... known for a long time that mutual antagonism between husband ... It has now been possible to pinpoint the exact reason. ... of coronary arteries (atherosclerosis) in women while controlling behavior of ... in men. ,Dr. Tim Smith and fellow researchers ...
... cancer, new research seems to say, as vaccines for ... ingredient//. ,Vaccines work by allowing the body’s immune system ... the immune system finds it difficult to distinguish the ... researchers at University College London (UCL) have been able ...
... scientists from University of New South Wales have ... inflammatory stages of glandular fever// could lead to chronic ... be related to specific regions of the brain that ... fatigue. An acute glandular fever infection could damage ...
... from a crippling mosquito-borne virus disease the Chikungunya fever. It ... area//. The World Health Organization (WHO) said that the ... Ocean region. ,This disease has no cure or ... Mauritius and Seychelles since January. The disease was first recognized ...
... it was found that GlaxoSmithKline Plc which funded the ... in infants// said that the vaccine was viable. GlaxoSmithKline ... ,Roman Prymula, who led the study at the Czech ... necessary before the vaccine hits the market. ...
... Trust plastic surgeons to be greedier! Not satisfied with ... a French woman, plastic surgeons are hungry to perform ... March issue of Plastic and Reconstructive Surgery? (PRS), the ... Surgeons (ASPS), U.S. plastic surgeons demonstrated the procedure of ...
Cached Medicine News:Health News:Heart disease: Men Are From Mars, Women From Venus 2Health News:Brain Injury, A Consequence Of Glandular Fever Could Trigger Fatigue Syndrome 2Health News:Threat from Chikungunya, No Longer a Fear 2
... Horizontal Mini Gel Kit. Gel ... one comb and tapered baffles for casting ... UV transparent. Available in clear, blue, ... supplies, gel trays, gel casters, single and ...
... advantages for nucleic acid separation, and have ... biologist. Agarose gels are easy to cast ... sample underlaying and prevent electrical field discontinuities ... Horizontal systems are more economical and easier ...
... The Mini-Sub cell GT system, ... is used for submerged horizontal gel ... format 7 x 10 cm agarose ... cell, 7 x 10 cm UV-transparent ...
Wide Mini ReadySub-Cell GT Cell, includes buffer tank, lid and electrodes, leveling bubble; accommodates 20-well, 32-well, and 2 x 32-well wide mini ReadyAgarose gels...
Medicine Products: